Aquestive Therapeutics (AQST) Competitors $3.24 -0.17 (-4.99%) As of 12:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AQST vs. ANIP, TVTX, BGM, AMPH, CALT, GPCR, AUPH, WVE, NAGE, and MLYSShould you be buying Aquestive Therapeutics stock or one of its competitors? The main competitors of Aquestive Therapeutics include ANI Pharmaceuticals (ANIP), Travere Therapeutics (TVTX), Qilian International Holding Group (BGM), Amphastar Pharmaceuticals (AMPH), Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Niagen Bioscience (NAGE), and Mineralys Therapeutics (MLYS). These companies are all part of the "pharmaceutical products" industry. Aquestive Therapeutics vs. Its Competitors ANI Pharmaceuticals Travere Therapeutics Qilian International Holding Group Amphastar Pharmaceuticals Calliditas Therapeutics AB (publ) Structure Therapeutics Aurinia Pharmaceuticals Wave Life Sciences Niagen Bioscience Mineralys Therapeutics Aquestive Therapeutics (NASDAQ:AQST) and ANI Pharmaceuticals (NASDAQ:ANIP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Which has more volatility & risk, AQST or ANIP? Aquestive Therapeutics has a beta of 1.94, suggesting that its stock price is 94% more volatile than the S&P 500. Comparatively, ANI Pharmaceuticals has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Does the MarketBeat Community believe in AQST or ANIP? ANI Pharmaceuticals received 223 more outperform votes than Aquestive Therapeutics when rated by MarketBeat users. However, 68.55% of users gave Aquestive Therapeutics an outperform vote while only 64.19% of users gave ANI Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAquestive TherapeuticsOutperform Votes21868.55% Underperform Votes10031.45% ANI PharmaceuticalsOutperform Votes44164.19% Underperform Votes24635.81% Do analysts recommend AQST or ANIP? Aquestive Therapeutics presently has a consensus price target of $10.14, indicating a potential upside of 213.05%. ANI Pharmaceuticals has a consensus price target of $80.13, indicating a potential upside of 28.90%. Given Aquestive Therapeutics' higher possible upside, equities research analysts plainly believe Aquestive Therapeutics is more favorable than ANI Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aquestive Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00ANI Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has better earnings and valuation, AQST or ANIP? ANI Pharmaceuticals has higher revenue and earnings than Aquestive Therapeutics. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than Aquestive Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAquestive Therapeutics$54.23M5.93-$7.87M-$0.59-5.49ANI Pharmaceuticals$674.07M2.00$18.78M-$1.27-48.94 Is AQST or ANIP more profitable? ANI Pharmaceuticals has a net margin of -1.28% compared to Aquestive Therapeutics' net margin of -59.75%. ANI Pharmaceuticals' return on equity of 15.87% beat Aquestive Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aquestive Therapeutics-59.75% N/A -33.96% ANI Pharmaceuticals -1.28%15.87%6.88% Does the media prefer AQST or ANIP? In the previous week, ANI Pharmaceuticals had 1 more articles in the media than Aquestive Therapeutics. MarketBeat recorded 6 mentions for ANI Pharmaceuticals and 5 mentions for Aquestive Therapeutics. Aquestive Therapeutics' average media sentiment score of 1.60 beat ANI Pharmaceuticals' score of 1.58 indicating that Aquestive Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aquestive Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive ANI Pharmaceuticals 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals believe in AQST or ANIP? 32.5% of Aquestive Therapeutics shares are owned by institutional investors. Comparatively, 76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 8.4% of Aquestive Therapeutics shares are owned by insiders. Comparatively, 12.7% of ANI Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryANI Pharmaceuticals beats Aquestive Therapeutics on 10 of the 17 factors compared between the two stocks. Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AQST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AQST vs. The Competition Export to ExcelMetricAquestive TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$321.82M$6.92B$5.60B$8.61BDividend YieldN/A2.55%5.28%4.18%P/E Ratio-7.208.8427.2219.97Price / Sales5.93255.17408.95152.58Price / CashN/A65.8538.2534.64Price / Book-2.046.587.114.68Net Income-$7.87M$144.20M$3.24B$248.05M7 Day Performance-9.24%3.32%2.47%2.40%1 Month Performance13.68%10.53%8.66%6.14%1 Year Performance15.30%3.63%31.22%13.62% Aquestive Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AQSTAquestive Therapeutics1.7624 of 5 stars$3.24-5.0%$10.14+213.1%+21.4%$321.82M$54.23M-7.20160Positive NewsAnalyst RevisionANIPANI Pharmaceuticals4.2275 of 5 stars$63.18+2.0%$80.13+26.8%-3.3%$1.37B$674.07M-114.87600Positive NewsTVTXTravere Therapeutics2.5183 of 5 stars$14.91-2.7%$31.79+113.2%+105.4%$1.32B$273.53M-3.64460Trending NewsAnalyst ForecastAnalyst RevisionBGMQilian International Holding GroupN/A$13.20+0.9%N/AN/A$1.28B$25.10M0.00298Positive NewsHigh Trading VolumeAMPHAmphastar Pharmaceuticals3.6605 of 5 stars$26.62+2.4%$32.33+21.5%-36.7%$1.25B$730.66M8.871,620CALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180GPCRStructure Therapeutics2.49 of 5 stars$20.51-2.9%$76.50+273.0%-54.6%$1.18BN/A-27.72136News CoveragePositive NewsAnalyst RevisionAUPHAurinia Pharmaceuticals3.3362 of 5 stars$8.14-0.6%$11.50+41.3%+45.8%$1.10B$247.30M-54.26300Positive NewsAnalyst RevisionWVEWave Life Sciences4.4461 of 5 stars$7.05-2.4%$21.17+200.2%+16.0%$1.09B$104.94M-6.35240News CoveragePositive NewsAnalyst ForecastAnalyst RevisionNAGENiagen Bioscience1.4854 of 5 stars$13.43+3.7%$18.00+34.0%N/A$1.06B$107.93M79.00120News CoverageAnalyst ForecastMLYSMineralys Therapeutics3.0623 of 5 stars$16.19+0.4%$38.00+134.7%+19.7%$1.06BN/A-4.4528Positive NewsAnalyst Forecast Related Companies and Tools Related Companies ANIP Alternatives TVTX Alternatives BGM Alternatives AMPH Alternatives CALT Alternatives GPCR Alternatives AUPH Alternatives WVE Alternatives NAGE Alternatives MLYS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AQST) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AQST Stock Free AQST Stock Alerts